85 related articles for article (PubMed ID: 12883734)
1. Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Alonso ME; Lomas J; De Campos JM; Kusak ME; Gutierrez M; Sarasa JL; Rey JA
Oncol Rep; 2003; 10(5):1519-23. PubMed ID: 12883734
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of multiple genes in astrocytic gliomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
[TBL] [Abstract][Full Text] [Related]
3. CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas.
Gonzalez-Gomez P; Bello MJ; Alonso ME; Lomas J; Arjona D; Campos JM; Vaquero J; Isla A; Lassaletta L; Gutierrez M; Sarasa JL; Rey JA
Clin Cancer Res; 2003 Nov; 9(15):5601-6. PubMed ID: 14654541
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
[TBL] [Abstract][Full Text] [Related]
5. Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8.
Bello MJ; De Campos JM; Isla A; Casartelli C; Rey JA
Oncol Rep; 2006 Feb; 15(2):443-8. PubMed ID: 16391867
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic changes in pilocytic astrocytomas and medulloblastomas.
Gonzalez-Gomez P; Bello MJ; Lomas J; Arjona D; Alonso ME; Amiñoso C; De Campos JM; Vaquero J; Sarasa JL; Casartelli C; Rey JA
Int J Mol Med; 2003 May; 11(5):655-60. PubMed ID: 12684707
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation status of multiple genes in brain metastases of solid tumors.
Gonzalez-Gomez P; Bello MJ; Alonso ME; Amiñoso C; Lopez-Marin I; De Campos JM; Isla A; Gutierrez M; Rey JA
Int J Mol Med; 2004 Jan; 13(1):93-8. PubMed ID: 14654977
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors.
Bello MJ; Alonso ME; Amiñoso C; Anselmo NP; Arjona D; Gonzalez-Gomez P; Lopez-Marin I; de Campos JM; Gutierrez M; Isla A; Kusak ME; Lassaletta L; Sarasa JL; Vaquero J; Casartelli C; Rey JA
Mutat Res; 2004 Oct; 554(1-2):23-32. PubMed ID: 15450401
[TBL] [Abstract][Full Text] [Related]
9. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
Kang GH; Lee S; Lee HJ; Hwang KS
J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
[TBL] [Abstract][Full Text] [Related]
10. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer.
Kim HC; Roh SA; Ga IH; Kim JS; Yu CS; Kim JC
J Gastroenterol Hepatol; 2005 Dec; 20(12):1920-6. PubMed ID: 16336454
[TBL] [Abstract][Full Text] [Related]
11. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
12. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
13. Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.
Morris MR; Hesson LB; Wagner KJ; Morgan NV; Astuti D; Lees RD; Cooper WN; Lee J; Gentle D; Macdonald F; Kishida T; Grundy R; Yao M; Latif F; Maher ER
Oncogene; 2003 Oct; 22(43):6794-801. PubMed ID: 14555992
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
15. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation status of multiple genes in uveal melanoma.
Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
[TBL] [Abstract][Full Text] [Related]
17. Deletion and aberrant CpG island methylation of Caspase 8 gene in medulloblastoma.
Gonzalez-Gomez P; Bello MJ; Inda MM; Alonso ME; Arjona D; Amiñoso C; Lopez-Marin I; de Campos JM; Sarasa JL; Castresana JS; Rey JA
Oncol Rep; 2004 Sep; 12(3):663-6. PubMed ID: 15289853
[TBL] [Abstract][Full Text] [Related]
18. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
[TBL] [Abstract][Full Text] [Related]
19. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients.
Yang HJ; Liu VW; Wang Y; Chan KY; Tsang PC; Khoo US; Cheung AN; Ngan HY
Gynecol Oncol; 2004 May; 93(2):435-40. PubMed ID: 15099958
[TBL] [Abstract][Full Text] [Related]
20. Aberrant gene promoter methylation in plasma cell dyscrasias.
Martin P; Garcia-Cosio M; Santon A; Bellas C
Exp Mol Pathol; 2008 Jun; 84(3):256-61. PubMed ID: 18410922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
